Brain imaging and histopathological studies have suggested that iron plays a crucial part in the pathophysiology of multiple sclerosis (MS). In this Review, Yong and colleagues discuss the growing evidence of widespread dysregulation of iron metabolism associated with MS, from focal iron deposits around grey matter lesions to iron deficits in white matter that might interfere with remyelination and other cellular repair processes. The authors then outline several potential mechanisms for treating iron dysregulation that balance the trophic and toxic properties of this molecule.
- Erin Stephenson
- Nabeela Nathoo
- V. Wee Yong